Troy Wanandy

Affiliation: University of Queensland
Institution: University of Queensland
ORCID: 0000-0003-4703-0488
External IDs: Loop profile: 1304317
Email: t.wanandy@uq.edu.au
Works: 25, Cited by: 123, H-index: 10
Researcher in the field of venom immunotherapy and clinical pharmaceutics.

Education

  • PhD, University of Queensland (2010-2014)

Research Interests

Keywords:
Venom Immunotherapy Allergen Immunotherapy Insect venom allergy Drug allergy Clinical Pharmaceutics Stability of Pharmaceuticals Good Manufacturing Practice
Topics:
Immunotherapy Allergy Pharmaceuticals

Professional Links

Selected Publications

Advax enhances ant venom therapy
Wanandy T, Honda-Okubo Y, Davies NW, Rose HE, Heddle RJ, et al. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy. J Pharm Biomed Anal. 2019;172:1. doi:10.1016/j.jpba.2019.04.017
PubMed DOI

Related Products